El-Haddad G - Search Results

1

Phase 3 Trial of ¹⁷⁷Lu-Dotatate for Midgut Neuroendocrine Tumors.

Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Strosberg J, et al. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. N Engl J Med. 2017. PMID: 28076709 Free PMC article. Clinical Trial.

2

¹⁷⁷Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors.

Das S, Al-Toubah T, El-Haddad G, Strosberg J. Das S, et al. Expert Rev Gastroenterol Hepatol. 2019 Nov;13(11):1023-1031. doi: 10.1080/17474124.2019.1685381. Epub 2019 Oct 30. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31652074 Free PMC article. Review.

3

An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol.

Bhutani MS, Klapman JB, Tuli R, El-Haddad G, Hoffe S, Wong FCL, Chasen B, Fogelman DR, Lo SK, Nissen NN, Hendifar AE, Varadhachary G, Katz MHG, Erwin WD, Koay EJ, Tamm EP, Singh BS, Mehta R, Wolff RA, Soman A, Cazacu IM, Herman JM. Bhutani MS, et al. Endosc Ultrasound. 2020 Jan-Feb;9(1):24-30. doi: 10.4103/eus.eus_44_19. Endosc Ultrasound. 2020. PMID: 31670288 Free PMC article.

4

Molecular imaging and radionuclide therapy of neuroendocrine tumors.

Haider M, Al-Toubah T, El-Haddad G, Strosberg J. Haider M, et al. Curr Opin Endocrinol Diabetes Obes. 2020 Feb;27(1):16-21. doi: 10.1097/MED.0000000000000519. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 31789833 Review.

5

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy.

Hope TA, Bodei L, Chan JA, El-Haddad G, Fidelman N, Kunz PL, Mailman J, Menda Y, Metz DC, Mittra ES, Pryma DA, Reidy-Lagunes DL, Singh S, Strosberg JR. Hope TA, et al. J Nucl Med. 2020 Feb;61(2):222-227. doi: 10.2967/jnumed.119.240911. J Nucl Med. 2020. PMID: 32015164 Free PMC article. No abstract available.

6

Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy.

Strosberg JR, Al-Toubah T, Pellè E, Smith J, Haider M, Hutchinson T, Fleming JB, El-Haddad G. Strosberg JR, et al. J Nucl Med. 2021 Jan;62(1):69-72. doi: 10.2967/jnumed.120.242875. Epub 2020 May 22. J Nucl Med. 2021. PMID: 32444368 Free article.

7

Desmoplastic mesenteric lesions do not respond radiographically to peptide receptor radionuclide therapy.

Pelle E, Al-Toubah T, Morse B, El-Haddad G, Strosberg J. Pelle E, et al. J Neuroendocrinol. 2021 Feb;33(2):e12936. doi: 10.1111/jne.12936. Epub 2021 Jan 20. J Neuroendocrinol. 2021. PMID: 33474756

8

Somatostatin receptor radionuclide therapy in neuroendocrine tumors.

Haider M, Das S, Al-Toubah T, Pelle E, El-Haddad G, Strosberg J. Haider M, et al. Endocr Relat Cancer. 2021 Mar;28(3):R81-R93. doi: 10.1530/ERC-20-0360. Endocr Relat Cancer. 2021. PMID: 33608483 Free PMC article. Review.

9

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with ¹⁷⁷Lu-DOTATATE.

Strosberg JR, Srirajaskanthan R, El-Haddad G, Wolin EM, Chasen BR, Kulke MH, Bushnell DL, Caplin ME, Baum RP, Hendifar AE, Öberg K, Ruszniewski P, Santoro P, Broberg P, Leeuwenkamp OR, Krenning EP. Strosberg JR, et al. J Nucl Med. 2021 Mar 26;62(12):1712-8. doi: 10.2967/jnumed.120.258897. Online ahead of print. J Nucl Med. 2021. PMID: 33771903 Free PMC article.

10

Preclinical evaluation of [²²⁵Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms.

Tafreshi NK, Pandya DN, Tichacek CJ, Budzevich MM, Wang Z, Reff JN, Engelman RW, Boulware DC, Chiappori AA, Strosberg JR, Ji H, Wadas TJ, El-Haddad G, Morse DL. Tafreshi NK, et al. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3408-3421. doi: 10.1007/s00259-021-05315-1. Epub 2021 Mar 26. Eur J Nucl Med Mol Imaging. 2021. PMID: 33772332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page